David Tepper, billionaire investor and one of the world’s top hedge-fund managers, isn't a fan of the stock market, right now.
Fed Chair Powell, joined by Treasury Secretary Yellen, delivers his opening statement to the Senate Banking Committee, which touched on COVID, inflation, the labor market, and GDP growth.
Shares of biopharma company Vir Biotechnology (NASDAQ: VIR) are up 13.7% as of 11:57 a.m. ET on Monday in response to reports that a new strain of the COVID-19 virus has been identified. Indeed, headlines regarding the new omicron variant of the coronavirus began to surface before Thursday's Thanksgiving holiday. It just took a while for investors to connect the dots all the way back to Vir Biotechnology, which potentially benefits from a renewed outbreak of infections stemming from this new strain of the pandemic-causing virus.
On Nov. 15, institutional investors and hedge funds with at least $100 million in assets under management were required to file Form 13F with the Securities and Exchange Commission (SEC). With the latest round of 13Fs, one thing stands out: billionaires were buying stocks hand over fist. Billionaire Ken Griffin is a wildly successful investor who's known for extracting big wins from his firms' options positions.
Those following along with Clover Health Investments, Corp. ( NASDAQ:CLOV ) will no doubt be intrigued by the recent...
Shares of Apple (NASDAQ: AAPL) stock closed up 2.2% on Monday following a holiday weekend that featured new commentary on the company and its products from Bloomberg. Last week, if you recall, Apple shares got a boost from reports that the company is planning to build an electric car with autonomous driving capability and also has an augmented reality headset in the works -- one that will be powerful enough to work as a stand-alone device. Well, over the weekend, Bloomberg expanded on these reports, adding that Apple is also working to develop augmented reality (AR) glasses (i.e., something different from the headset) and predicting that consumers (and investors) might get their first look at the AR headset as early as June 2022 if the company decides to unveil it at Apple's planned Worldwide Developers Conference next June.
After hitting an all-time high of nearly $300 per share earlier this year, shares of CrowdStrike (NASDAQ: CRWD) have slid sharply recently. Trading at about $225 headed into the company's earnings report later this week, the stock is approximately down 25% from its all-time high. Can tech company's upcoming earnings report help revitalize interest in the stock?
Yahoo Finance Live's Julie Hyman breaks down some of the leading national headlines.
The graphics specialist's dominance in this multibillion-dollar market is great news for investors.
The nation’s economic steward said it will back off of using the word “transitory” to describe the fast pace of price increases, as Federal Reserve policymakers acknowledge the increasing risk of more persistent inflation.
It was a hot investment during the early stages of the pandemic, but that isn't the case anymore.
Wall Street has known its share of legends, but few of them have made as big a splash as “the Man Who Broke the Bank of England.” That nickname belongs to George Soros who earned the tag after famously betting against the British Pound in 1992; following the Black Wednesday crash, the hedge fund manager pocketed $1 billion in a single day. This is the stuff that Wall Street legends are made of. By then Soros was already incredibly successful and in the midst of steering his Quantum Fund to decad
Adagio Therapeutics Inc. is riding high after the company said its experimental antibody is likely to be just as effective against the omicron variant of the coronavirus as it is against previous variants. The antibody, a drug called ADG20, affords protection for up to one year, according to the firm.
Ideally, your overall portfolio should beat the market average. But even the best stock picker will only win with some...
Stock prices can go up and down for a number of reasons in the near term, but over many years, stocks tend to follow the underlying growth of the company. While Alibaba (NYSE: BABA) and Stitch Fix (NASDAQ: SFIX) have seen their share prices crater this year, both companies continue to post solid operating results. Here's why these growth stocks could be bargains at current prices.
Honeywell International (NASDAQ: HON) appears to be the next company in line for a breakup after its iconic peer, General Electric (NYSE: GE), announced plans to separate into three different companies over the next few years. The subject last received a highly vocal airing in 2017 when an activist hedge fund campaigned for Honeywell to spin off its aerospace business. The businesses would be valued higher by the market if management separated them than if they were still part of Honeywell.
Sundial Growers (NASDAQ: SNDL) has come a long way since its explosion onto the public scene and its brief tenure as a meme stock. Formerly a small regional marijuana company in Canada, Sundial has effectively leveraged its popularity to become something more than a cannabis seller, and it now has a shot at becoming a serious player in the industry. Rather than prioritizing growing and selling marijuana, Sundial is positioning itself to be a kingmaker and principal investor for smaller cannabis companies in Canada.
The professor is known for being bullish on stocks, yet even he says trouble’s coming.
If you're a fan of stable healthcare companies that have the potential to pay you ever-rising dividends until the cows come home, Viatris (NASDAQ: VTRS) might well become a dream stock. The single most persuasive argument against it being too late to buy Viatris is that the company is just getting started. After all, its life as an independent entity started a mere year ago with the merger of Pfizer's generic drugs business, Upjohn, and Mylan.
Intel (NASDAQ: INTC) started 2021 with a bang, with shares of the chip giant accelerating in the first quarter of the year thanks to news that it may be gaining ground against rival Advanced Micro Devices (NASDAQ: AMD). Shares of Intel are now trading close to the lower end of their 52-week range. Wall Street doesn't seem to be too optimistic about the company's prospects either, as the stock has an average price target of $54, which points toward a tepid upside from current levels.
CEO Satya Nadella sold about half his stake in the software company, according to recent filings with the Securities and Exchange Commission.